Siddartha Tamang

Siddartha Tamang

Auto-generated profile, based on publicly available information

Siddartha Tamang

Department of Chemical Engineering and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
RRRitu Raman
Ritu Raman
THTiffany Hua
Tiffany Hua
DGDeclan Gwynne
Declan Gwynne
JCJoy Collins
Joy Collins
STSiddartha Tamang
Siddartha Tamang
GTGiovanni Traverso
Giovanni Traverso
Light-triggerable hydrogels enable on-demand degradation of gastrointestinal-resident devices, reducing the need for invasive interventions.

14 June 2021 in Nature Materials
Verified
Journal Article
Closed access
PDF file
SBSahab Babaee
Sahab Babaee
YSYichao Shi
Yichao Shi
SASaeed Abbasalizadeh
Saeed Abbasalizadeh
STSiddartha Tamang
Siddartha Tamang
KHKaitlyn Hess
Kaitlyn Hess
GTGiovanni Traverso
Giovanni Traverso

28 August 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
AAAlex Abramson
Alex Abramson
DDDavid Dellal
David Dellal
YKYong Lin Kong
Yong Lin Kong
JZJianlin Zhou
Jianlin Zhou
YGYuan Gao
Yuan Gao
GTGiovanni Traverso
Giovanni Traverso
An ingestible device injects probes into stomach tissue for electrical stimulation and potential treatment of gastroparesis.

26 August 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
JLJunwei Li
Junwei Li
TWThomas Wang
Thomas Wang
AKAmeya R. Kirtane
Ameya R. Kirtane
YSYunhua Shi
Yunhua Shi
AJAlexis Jones
Alexis Jones
GTGiovanni Traverso
Giovanni Traverso
A targeted coating of polydopamine polymerized in situ in the small intestine enables drug delivery and modulation of nutrient absorption in pigs.

27 May 2022 in Science Advances
Verified
Journal Article
Open access
AKAmeya R. Kirtane
Ameya R. Kirtane
Christina KaravasiliChristina Karavasili
Christina Karavasili
AWAniket Wahane
Aniket Wahane
DFDylan Freitas
Dylan Freitas
KBKatelyn Booz
Katelyn Booz
GTGiovanni Traverso
Giovanni Traverso
Administering medicines to 0- to 5-year-old children in a resource-limited environment requires dosage forms that circumvent swallowing solids, avoid on-field reconstitution, and are thermostable, cheap, versatile, and taste masking. We present a strategy that stands to solve this multifaceted problem. As many drugs lack adequate water solubility, our formulations used oils, whose textures could be modified with gelling agents to form “oleogels.” In a clinical study, we showed that the oleogels can be formulated to be as fluid as thickened beverages and as stiff as yogurt puddings. In swine, oleogels could deliver four drugs ranging three orders of magnitude in their water solubilities and two orders of magnitude in their partition coefficients. Oleogels could be stabilized at 40°C for prolonged durations and used without redispersion. Last, we developed a macrofluidic system enabling fixed and metered dosing. We anticipate that this platform could be adopted for pediatric dosing, palliative care, and gastrointestinal disease applications.

4 December 2019 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
AKAmeya R. Kirtane
Ameya R. Kirtane
THTiffany Hua
Tiffany Hua
AHAlison Hayward
Alison Hayward
ABAmbika Bajpayee
Ambika Bajpayee
AWAniket Wahane
Aniket Wahane
GTGiovanni Traverso
Giovanni Traverso
An oral dosage form that resides in the stomach releases the contraceptive levonorgestrel over 1 month in pigs.